Search Within
Applications
Content Type
Viral Vector Vaccine Manufacturing
Applied Filters:
facet applications:Viral Vector Vaccine Manufacturing
Showing 1-5 of 5 results
High Performing Platforms for Lentivirus and AAV Manufacturing
Upstream gene therapy optimization maximizes viral vector titers; partner with technology experts for HEK293, HEK293T, and Sf9 cell solutions.
DCAT Week
If you're planning to attend DCAT Week this year, stop by the Dunhill and Century suites at the Benjamin Royal Sonesta and meet the MilliporeSigma team.
BIO International
We warmly invite you to visit booth 4735 at BIO International and connect with the MilliporeSigma team.
Protein Fingerprinting of a Viral Vector, AAV5
Method development for protein fingerprinting of AAV serotype 5
using both intact mass analysis and peptide mapping, to determine critical quality attributes for gene therapy, utilizing three different columns.
Scalable Tangential Flow Filtration (TFF) for Downstream Processing of Viral Vectors for Gene Therapy and Vaccine Production
Our overview of scalable tangential flow filtration for viral vector production will provide key considerations for developing and optimizing your downstream process.